DESVENLAFAXINE SUCCINATE and MALAISE

1,034 reports of this reaction

1.9% of all DESVENLAFAXINE SUCCINATE reports

#11 most reported adverse reaction

Overview

MALAISE is the #11 most commonly reported adverse reaction for DESVENLAFAXINE SUCCINATE, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.. There are 1,034 FDA adverse event reports linking DESVENLAFAXINE SUCCINATE to MALAISE. This represents approximately 1.9% of all 53,036 adverse event reports for this drug.

Patients taking DESVENLAFAXINE SUCCINATE who experience malaise should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

MALAISE1,034 of 53,036 reports

MALAISE is a less commonly reported adverse event for DESVENLAFAXINE SUCCINATE, but still significant enough to appear in the safety profile.

Other Side Effects of DESVENLAFAXINE SUCCINATE

In addition to malaise, the following adverse reactions have been reported for DESVENLAFAXINE SUCCINATE:

Other Drugs Associated with MALAISE

The following drugs have also been linked to malaise in FDA adverse event reports:

0XYGENACETAMINOPHENACETAMINOPHEN 500MGACETAMINOPHEN AND CODEINE PHOSPHATEACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDEACETAMINOPHEN AND IBUPROFENACETAMINOPHEN, ASPIRIN, AND CAFFEINEACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINEACETAMINOPHEN, CAFFEINEACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATEACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCLACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATEACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDEACETAMINOPHEN, DIPHENHYDRAMINE HCLACETAMINOPHEN, DIPHENHYDRAMINE HCL, PHENYLEPHRINE HCLACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE

Frequently Asked Questions

Does DESVENLAFAXINE SUCCINATE cause MALAISE?

MALAISE has been reported as an adverse event in 1,034 FDA reports for DESVENLAFAXINE SUCCINATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is MALAISE with DESVENLAFAXINE SUCCINATE?

MALAISE accounts for approximately 1.9% of all adverse event reports for DESVENLAFAXINE SUCCINATE, making it a notable side effect.

What should I do if I experience MALAISE while taking DESVENLAFAXINE SUCCINATE?

If you experience malaise while taking DESVENLAFAXINE SUCCINATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages

DESVENLAFAXINE SUCCINATE Full ProfileAll Drugs Causing MALAISEWyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. Drugs
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.